Evaluate the Efficacy of Armodafinil for Patients With B-cell Lymphoma and Severe Fatigue
- Status
- WITHDRAWN
- Phase
- NA
Clinical Trials Related to B-cell Lymphoma
Related studies linked through entity extraction aliases.
CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
High-dose Chemotherapy With Rituximab for Adults With Aggressive Large B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab
- Status
- TERMINATED
- Phase
- PHASE2
Study of 90Y-DOTA-hLL2 as a Consolidation Therapy After R-CHOP in Patients With Diffuse Large B-cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
High Dose Rituximab for Initial Treatment of Indolent B-Cell Lymphomas
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
R-CHOP-B Bevacizumab for Diffuse Large B Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
High Dose, Absorbed Dose Adjusted 90Y-ibritumomab With Peripheral Blood Stem Cells (PBSC) Support in B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study for Patients With Non-Hodgkin's Lymphomas
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE3
Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Bexxar Therapy in the Treatment of Relapsed/Residual B-Cell Lymphoma After Autologous Transplant
- Status
- COMPLETED
- Phase
- PHASE1
Dose Escalation Study of Clofarabine in Patients With Relapsed or Refractory Low Grade or Intermediate-Grade B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of L-NDDP (Aroplatin) in Patients With Advanced Solid Malignancies or B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Study Evaluating Inotuzumab Ozogamicin [CMC-544] Administered In Combination With Rituximab In Subjects With Non-Hodgkin's Lymphoma (NHL)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase II Trial of Thalidomide in Refractory/Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin's Disease
- Status
- TERMINATED
- Phase
- PHASE2
Treatment of Mature B-cell Lymphoma/Leukaemia
- Status
- COMPLETED
- Phase
- PHASE3
Yttrium-90 Ibritumomab Tiuxetan (Zevalin) With BEAM in Relapsed Low Grade B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
An Investigational Drug Study With Suberoylanilide Hydroxamic Acid in Relapsed Diffuse Large B-cell Lymphoma (0683-013)
- Status
- COMPLETED
- Phase
- PHASE2